Penumbra Inc (PEN) stock
PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3074% above fair value
$320.60+1.49 (+0.47%)
Close on Nov 18, 2026Market cap $12.64BP/E 80.8Yield –
Penumbra pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Penumbra's pe ratio was 79.0× on Nov 11, 2026, against 70.8× a year earlier. Over the last 5 years it ranged from 61.1× to 900.1×, with a median of 203.6×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 79.0× | +3.9 |
| 2025 | Dec 31, 2025 | 75.1× | −201.0 |
| 2024 | Dec 31, 2024 | 276.1× | +31.9 |
| 2023 | Dec 29, 2023 | 244.2× | −4.2 |
| 2022 | Jan 31, 2022 | 248.4× | −67.4 |
| 2021 | Dec 31, 2021 | 315.7× | −584.4 |
| 2020 | Oct 30, 2020 | 900.1× | +769.7 |
| 2019 | Dec 31, 2019 | 130.4× | −425.1 |
| 2018 | Dec 31, 2018 | 555.5× | −282.5 |
| 2017 | Oct 31, 2017 | 837.9× | +724.0 |
| 2016 | Dec 30, 2016 | 113.9× | −304.7 |
| 2015 | Oct 30, 2015 | 418.6× | – |
See a number that looks wrong?